News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Sarepta Therapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Wall Street Cheers As Sarepta Soars 50% Premarket on Muscular Dystrophy Drug Filing
May 20, 2015
·
6 min read
Genetown
Q&A With Former CEO Of Sarepta
April 29, 2015
·
1 min read
Genetown
Interview With Sarepta’s New CEO
April 3, 2015
·
1 min read
Business
Sarepta CEO Resigns Abruptly, Was “In Over His Head”
April 1, 2015
·
4 min read
Drug Development
Despite CEO’s Comments, Experimental Sarepta Drug Protects Lab Monkeys From Ebola
February 11, 2015
·
5 min read
Pharm Country
BIOCEO15: Sarepta CEO Feels Backlash After Saying Ebola Research Isn’t in “Shareholder Interest”
February 9, 2015
·
3 min read
Drug Development
BioMarin, Sarepta Rivalry Gets Nasty in Battle Over Data
January 19, 2015
·
3 min read
Drug Development
Breaking: J.P. Morgan: BioMarin Takes Shot at Sarepta, Says DMD Drug Has Better Results So Far
January 12, 2015
·
3 min read
Business
Ex-Sarepta Therapeutics Exec to Head Massachusetts Startup Checkmate Pharmaceuticals
December 30, 2014
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 28, 2020
April 30, 2020
·
2 min read
Business
Sarepta Therapeutics to Announce First Quarter 2020 Financial Results and Recent Corporate Developments on May 6, 2020
April 29, 2020
·
1 min read
Business
Sarepta Therapeutics Announces Research Agreement with U.S. Department of Defense to Evaluate Multiple Constructs From its Proprietary RNA Platform as Treatments for COVID-19
April 28, 2020
·
6 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2020
March 31, 2020
·
2 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Feb. 28, 2020
February 28, 2020
·
2 min read
Genetown
Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship Program
February 27, 2020
·
3 min read
Business
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments
February 26, 2020
·
30 min read
Business
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2019 Financial Results and Recent Corporate Developments on February 26, 2020
February 19, 2020
·
1 min read
Deals
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan. 31, 2020
January 31, 2020
·
2 min read
Business
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
January 13, 2020
·
5 min read
